MATRIXLABS

Matrix Laboratories Limited has informed the Exchange vide its letter dated May 07, 2009 that "Mylan Inc., USA, (Mylan) the ultimate holding company of Matrix Laboratories Limited (Matrix) has reported the unaudited interim consolidated financials of Mylan for the quarter ended 31st March, 2009 under US GAAP reporting, which inter alia, included the following unaudited details of Matrix: Segment profitability (on a US GAAP basis) of $22,739,000 for the three months ended 31st March, 2009 (which includes the effect of $23,332,000 of inter-company revenues). Please note that financial results of

Matrix Laboratories Limited has informed the Exchange vide its letter dated April 30, 2009 that "Mylan Inc., USA, (Mylan) the ultimate holding company of Matrix Laboratories Limited (Matrix) has reported in its earnings release today (30th April, 2009 in the U.S.), the unaudited interim consolidated financials of Mylan for the quarter ended 31st March, 2009 under US GAAP reporting, which inter alia included the following unaudited details of Matrix: Net revenues (third party) for the three months ended 31st March, 2009 (on a US GAAP basis) - U.S. $ 102.6 million. Please note that financial res

Matrix Laboratories Limited has submitted to the Exchange a copy of the Notice regarding payment of calls-in-arrears from the partly paid-up shareholders of the Company. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/MATRIX_Updates_10112008.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange that the Board of Directors at their meeting held on July 29, 2008, the Board approved issue of a Final Notice to the Shareholders holding 23,218 partly paid up Equity Shares of Rs.2/- each, advising them to remit the calls-in-arrears along with interest on or before September 08, 2008.

Matrix Laboratories Limited has submitted to the Exchange a copy of the Abstract of terms issued to the members of the Company pursuant to Section 302 of the Companies Act, 1956 regarding appointment of Mr. Jagdish Vishwanath Dore, Chief Executive Officer as Managing Director. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Matrix_Abs_26072008.zip target=NEW> For more details click here.</a>

Matrix Laboratories Limited has informed the Exchange vide its letter dated May 12, 2008 that "Mylan Inc., USA, (Mylan) the ultimate holding company of Matrix Laboratories Limited (Matrix) has reported today (12th May, in the US), the unaudited interim consolidated financials of Mylan for the quarter ended 31st March, 2008 under US GAAP reporting, which inter alia included the following unaudited details of Matrix: Segment profitability (on a US GAAP basis) of $3,617,000 for the three months ended 31 March, 2008. Please note that financial results of Matrix for the quarter ended / year ended 3

Matrix Laboratories Limited has informed the Exchange vide its letter dated May 09, 2008 that "Mylan Inc., USA, (Mylan) the ultimate holding company of Matrix Laboratories Limited (Matrix) has reported today (8th May, in the U.S.), the unaudited interim consolidated financials of Mylan for the quarter ended 31st March, 2008 under US GAAP reporting, which inter alia included the following unaudited details of Matrix: Revenues for the three months ended 31 March, 2008 (on a US GAAP basis) of US $103 million, including third party sales of US$ 87.6 million. Please note that financial results of M